title: Hypomagnesemia in renal transplant patients: improvement over time and association with hypertension and cyclosporine levels.
abstract: Hypomagenesemia is frequently encountered early after kidney transplantation, especially in patients receiving cyclosporine (CsA). However, there have been no studies addressing the natural history of this disorder in adult transplant recipients. We conducted this investigation to study the change in the prevalence of hypomagnesemia over time in renal transplant patients as well as to determine the factors associated with this change. Three patient groups were studied: 24 CsA-treated patients followed longitudinally at 1, 3 and 6 months post-transplant (Group 1a, 1b, 1c); 33 CsA-treated patients at least 2 years post-transplant (Group 2; mean follow-up 55 +/- 25 months); and 31 non-CsA-treated patients at least 2 years post-transplant (Group 3; mean follow-up 132 +/- 57 months). The following parameters were monitored: serum and urine magnesium levels; serum potassium; creatinine clearance; fractional excretion of magnesium; and trough CsA levels. In group 1 patients, longitudinal follow-up showed a significant linear trend for improvement in the serum magnesium over time (1.6 +/- 0.3, 1.7 +/- 0.2, 1.8 +/- 0.2 mg/dl; p = 0.0015) as well as a decline in the whole blood CsA level (316 +/- 103, 251 +/- 82, 194 +/- 67 ng/ml; p = 0.0015) at 1, 3 and 6 months, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Medicine, College of Pharmacy, University of Florida, Gainesville 32610-0024, USA.
authors.forename: E L
authors.initials: EL
authors.lastname: Ramos
authors.forename: Y M
authors.initials: YM
authors.lastname: Barri
authors.forename: P
authors.initials: P
authors.lastname: Kubilis
authors.forename: J C
authors.initials: JC
authors.lastname: Peterson
authors.forename: W W
authors.initials: WW
authors.lastname: Pfaff
authors.forename: R J
authors.initials: RJ
authors.lastname: Howard
authors.forename: C J
authors.initials: CJ
authors.lastname: Parris
authors.forename: P R
authors.initials: PR
authors.lastname: Patton
authors.forename: J L
authors.initials: JL
authors.lastname: Karlix
mesh_terms: D000328:Adult; D003430:Cross-Sectional Studies; D016572:Cyclosporine / Q000097:blood* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000209:etiology*; D007166:Immunosuppressive Agents / Q000097:blood* / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000009:adverse effects*; D008137:Longitudinal Studies; D008274:Magnesium / Q000097:blood* / Q000652:urine; D008297:Male; D008875:Middle Aged
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D008274:Magnesium